Nakae Hajime, Irie Yasuhito, Kitamura Toshiharu, Okuyama Manabu
Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan.
Front Pharmacol. 2022 May 23;13:853012. doi: 10.3389/fphar.2022.853012. eCollection 2022.
Jidabokuippo (JDI) () has been used in Japan to alleviate contusion-induced swelling and pain since medieval times. This review investigated the effects of JDI on various symptoms in patients with trauma or static blood. The PubMed and Igaku Chuo Zasshi databases were searched until 24 December 2021. We summarize the benefits of applying JDI to inflammatory conditions, including bruises. JDI has been used to resolve blood stasis, regulate qi in trauma patients, and treat inflammatory swelling and pain caused by rheumatoid arthritis and cellulitis. As the adverse event rate associated with JDI is low (1.3%), JDI is considered a safe drug. JDI can be used to resolve blood stasis in trauma patients without adverse events associated with nonsteroidal anti-inflammatory drugs.
自中世纪以来,跌打万应膏(JDI)就在日本被用于减轻挫伤引起的肿胀和疼痛。本综述调查了JDI对创伤或瘀血患者各种症状的影响。检索了截至2021年12月24日的PubMed和《医学中央杂志》数据库。我们总结了将JDI应用于包括瘀伤在内的炎症性疾病的益处。JDI已被用于活血化瘀、调节创伤患者的气血,以及治疗类风湿性关节炎和蜂窝织炎引起的炎症性肿胀和疼痛。由于与JDI相关的不良事件发生率较低(1.3%),JDI被认为是一种安全的药物。JDI可用于创伤患者的活血化瘀,且无与非甾体抗炎药相关的不良事件。